COMMUNIQUÉS West-GlobeNewswire

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026
29/10/2026
Diranersen late-breaking symposium will feature 96-week long-term extension data and additional 76-week biomarker and clinical data from the Phase 2 CELIA study in early Alzheimer's disease Lecanemab presentations will [...]
Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
29/10/2026
DEER PARK, Ill., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting
29/10/2026
Pivotal, Phase 3 CHAPTER-3 data selected for late-breaking oral presentation on Saturday, November 14 ZUG, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company [...]
Biosplice Executives to Appear on Health Uncensored with Dr. Drew on Sunday, November 1
29/10/2026
Chief Executive Officer Erich Horsley and Chief Medical Officer Dr. Yusuf Yazici discuss the need for innovation in knee osteoarthritis and the development of lorecivivint, which is now under regulatory review in the [...]
Fortrea Reports Third Quarter 2026 Results
29/10/2026
Sustained commercial momentum, continued margin improvement, and targeted investments strengthen growth foundation Highlights For the three months ended September 30, 2026: Revenues of $691.5 million Book-to-bill ratio [...]
MINES and Associates Earns URAC Full Accreditation for Health Utilization Management
29/10/2026
The designation demonstrates a meaningful commitment to quality health care LITTLETON, Colo., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MINES and Associates (MINES) is proud to announce that it has earned URAC Full [...]
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call
29/10/2026
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Helsinn announces UK MHRA approval of AKYNZEO® Oral Suspension
29/10/2026
Lugano, Switzerland – October 29 th , 2026 – Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, today announced that the UK Medicines and [...]
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
29/10/2026
Positive Phase 2 ACUITY trial findings support Privosegtor’s potential to deliver a first-in-class neuroprotective treatment for patients with optic neuritis and beyond ZUG, Switzerland, October 29 th , 2026 -- Oculis [...]
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
29/10/2026
Positive Phase 2 ACUITY trial findings support Privosegtor’s potential to deliver a first-in-class neuroprotective treatment for patients with optic neuritis and beyond ZUG, Switzerland, October 29 th , 2026 -- Oculis [...]
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
29/10/2026
October 29, 2026 New CE-marked solution leverages the industry-leading Philips Azurion platform to integrate CT-derived insights and treatment planning directly into the procedural workflow, helping physicians make [...]
Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis
29/10/2026
ExoCordOA, a f ive-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clinical development, regulation, GMP manufacturing, imaging, [...]
ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
29/10/2026
Financing led by Asabys, with participation from CDTI with its SICC Innvierte and the Institut Català de Finances (ICF) Proceeds will accelerate the expansion of ALLOX’s high-throughput biophysics and AI drug discovery [...]
Coloplast opens new factory in Portugal to support global growth
29/10/2026
Coloplast today inaugurates its largest manufacturing site to date, a two-floor 50,000 m2 facility in Felgueiras, Portugal, expanding the company’s production capacity to meet growing global demand for continence care [...]
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
29/10/2026
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd. TME Pharma receives €150,000 for 6 months of exclusivity to negotiate a definitive agreement for worldwide rights to NOX-A12 TMS Co., [...]
TME Pharma signe un accord de négociation exclusif et contraignant avec la société japonaise TMS Co., Ltd.
29/10/2026
TME Pharma signe un accord de négociation exclusif et contraignant avec la société japonaise TMS Co., Ltd. TME Pharma TME Pharma reçoit 150 000 € en échange de 6 mois d’exclusivité pour négocier un accord définitif [...]
Vistin Pharma ASA (VISTN): Key information relating to the cash dividend
29/10/2026
The Board of Directors has resolved to pay an additional ordinary cash dividend of NOK 0.50 per share in November, pursuant to the authorization granted by the Annual General Meeting on 20 May 2026. Dividend amount (per [...]
Vistin Pharma ASA: Third quarter and YTD 2026 financial results
29/10/2026
Vistin Pharma ASA: Third quarter and YTD 2026 financial results Oslo, Norway, 29 October 2026 Vistin Pharma ASA (VISTN) today announces its financial results for the third quarter and year to date 2026. Revenue in the [...]
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off
29/10/2026
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off Rebuilt platform combines AI-powered 12-lead ECG analysis, editable findings, and clinician sign-off in one [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum